Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05171491 · ClinicalTrials.gov registry record
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
A clinical trial of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule, sponsored by LungLife AI.
- Active
- Registry status
- 425
- Enrollment target
- 12
- Study locations
NCT05171491: Active study of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule, sponsored by LungLife AI.
NCT05171491 is a study of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule that is active but no longer recruiting, run by LungLife AI. The registered enrollment target is 425 participants, below the 915-participant average among 4 other Multiple Pulmonary Nodules trials with a reported enrollment target (54% lower). The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05171491, a study of Multiple Pulmonary Nodules and Solitary Pulmonary Nodule, is active but no longer recruiting, sponsored by LungLife AI.
- ACTIVE NOT RECRUITING
- Registry status
- 425 participants
- Enrollment target
- 12
- Study locations
Study Summary
Correlate performance of LungLB Test with outcome of a scheduled biopsy.
Conditions Studied
Study Locations (12)
Florida
- Clinical Site 05 - Bay Pines
- Clinical Site 03 - Miami
Kansas
- Clinical Site 27 - Kansas City
- Clinical Site 12 - Wichita
California
- Clinical Site 04 - Los Angeles
Illinois
- Clinical Site 07 - Hines
Missouri
- Clinical Site 08 - Kansas City
Nevada
- Clinical Site 18 - Reno
New York
- Clinical Site 01 - New York
South Carolina
- Clinical Site 25 - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2022-01-26 |
| Est. Completion | 2024-09-02 |
What the registry record for NCT05171491 still lists
NCT05171491 is an observational study that tracks outcomes without assigning an intervention. The registered 425 participants enrollment target is mid-sized for trials with a published cap, below the 915-participant average among 4 other Multiple Pulmonary Nodules trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Multiple Pulmonary Nodules appearing as the primary indexed condition, and to 0 interventions.
NCT05171491 lists 12 locations in 10 states (Florida, Kansas, California).
Frequently Asked Questions
What is clinical trial NCT05171491 about?
NCT05171491 is a clinical study titled "LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules". Correlate performance of LungLB Test with outcome of a scheduled biopsy.
What is the current status of trial NCT05171491?
This trial is currently active not recruiting. The enrollment target is 425 participants. The study started on 2022-01-26. Estimated completion is 2024-09-02.
What conditions does trial NCT05171491 study?
This clinical trial studies the following conditions: Multiple Pulmonary Nodules, Solitary Pulmonary Nodule.
Who is sponsoring clinical trial NCT05171491?
This trial is sponsored by LungLife AI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05171491 being conducted?
This trial has 12 study locations across California, Florida, Illinois, Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Pulmonary Nodules
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules
ACTIVE NOT RECRUITING · NA
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
COMPLETED · Phase 2
-
A Multi-Center Trial of the ProLung Test™
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
- NCT05340738 · 425 participants · NA
AI-Based Fidelity Feedback to Enhance CBT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI